Active Pharmaceutical Ingredient (API) Market Market Size Worth USD 306.1 billion by 2027 | CAGR: 7.1%
Active Pharmaceutical Ingredient (API) Market Size Worth USD 306.1 billion by 2027
“According to Polaris Market Research report, Active Pharmaceutical Ingredient (API) Market is witnessing a major transformation and is projected to reach USD 306.1 billion by 2027 registering a CAGR of 7.1% during the forecast period 2020 to 2027.” The global Active Pharmaceutical Ingredient (API) Market growth is driven by some of the key factors such as growing awareness among consumers, increasing investments by private-public organizations, and favorable government policies. Additionally, many prominent players present in the market are concentrating on the adoption of new technology and product launches to obtain a competitive edge, which in turn contributes to the Active Pharmaceutical Ingredient (API) Market growth. The regulatory agencies are also playing a key role as the major driving force for the market, by safeguarding the quality of product/service offerings as well as accelerating new approvals.
Active Pharmaceutical Ingredient (API) Market Report Scope: The study provides a comprehensive view of the Active Pharmaceutical Ingredient (API) Market by product type, by form, by manufacturer, by application, and by geographic region. All the segments of the market have been thoroughly analyzed based on present and future trends. The research report has identified the key segments contributing most to the Viscosupplemnt market growth in terms of revenue along with other vital factors impacting the market dynamics. Further, the market analysis covered in the report also answers the imperative question for new entrants and existing players operating in the market. Browse Detailed Research Report On Active Pharmaceutical Ingredient (API) Market Analysis: https://www.polarismarketresearch.com/industry-analysis/active-pharmaceutical-ingredients-market
-2-
Active Pharmaceutical Ingredient (API) Market Size Worth USD 306.1 billion by 2027
By Product Type
By Form
Manufacturer
By Application
By Region
Type •
Monoclonal Antibodies
•
Aqueous
•
Captive
•
Cardiology
•
North America (U.S., Canada)
•
Immunoglobulin
•
•
Merchant
•
Oncology
•
•
NonAqueous
Cytokines
•
CNS & Neurology
•
Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria)
Dry Powder
•
Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
•
Latin America (Brazil, Mexico, Argentina)
•
Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
•
Insulin
•
Orthopedic
•
Peptide Hormones
•
Endocrinology
•
Blood Factors
•
Pulmonology
•
Peptide Antibiotics
•
Gastroenterology
•
Vaccines
•
Nephrology
•
Small Molecule Antibiotics
•
Ophthalmology
•
Others
•
Highly Potent Active Pharmaceutical Ingredient (HPAPI)
•
Others
Impact Analysis of COVID-19 on Aircraft Fuel Systems Market The global Active Pharmaceutical Ingredient (API) Market is anticipated to continue its growth amid the covid19 pandemic. After giving insightful information on market behavior pre and post COVID-19 pandemic, the report also sheds light on the key strategic moves to overcome the adverse impact of COVID-19 on business and turn the positive impact into a lucrative opportunity. Regional Outlook The regional market of North America is witnessing a significant rise in the growth rate and is expected to account for the largest market share over the forecast period. The market is flourishing as a result of its increasing application scope and ample availability of vital resources. During the forecast period, the Asia Pacific region is estimated to garner the highest CAGR for the Anti-Biofilm Wound Dressing Market, owing to the presence of several leading local and international players operating in the regional market.
-3-
Active Pharmaceutical Ingredient (API) Market Size Worth USD 306.1 billion by 2027
Gain access to our latest research report that includes a detailed analysis of the COVID-19 pandemic influencing the Active Pharmaceutical Ingredient (API) Market in different regions and how market players devising effective strategies to mitigate the effect of the pandemic: https://www.polarismarketresearch.com/industry-analysis/active-pharmaceutical-ingredientsmarket/speak-to-analyst Competitive Landscape Leading companies holding significant market shares in the Active Pharmaceutical Ingredient (API) Market are analyzed considering their market shares, growth rates, market revenue, business strategies, and latest developments. Recent events for these major companies such as acquisitions, research initiatives, technological advancements, new solution/product launches, and geographical expansions considered in finalizing their position in the market. According to Polaris Market Research, the leading players with a noteworthy share in the Aircraft Fuel Systems include AbbVie Inc., Albemarle Corporation, AstraZeneca, Aurobindo Pharma, Boehringer Ingelheim, Bristol-Myers Squibb, Cipla Inc., Dr. Reddy’s Laboratories Ltd., ELI Lilly and Company, F. Hoffmann-La Roche, GlaxoSmithKline PLC, Lonza Group, Merck & Co., Inc., Mylan N.V., Novartis AG, Pfizer, Inc., Sanofi, Sun Pharmaceutical Industries Ltd, and Teva Pharmaceutical Industries Ltd. Request for sample: https://www.polarismarketresearch.com/industry-analysis/active-pharmaceuticalingredients-market/request-for-sample
Table of Contents 1. Introduction 1.1. Report Description 1.1.1.Objectives of the Study 1.1.2.Market Scope 1.1.3.Assumptions 1.2. Stakeholders 2. Executive Summary 2.1. Market Highlights 3. Research Methodology 3.1. Overview 3.1.1.Data Mining 3.2. Data Sources 3.2.1.Primary Sources 3.2.2.Secondary Sources 4. Active Pharmaceutical Ingredient Market Insights 4.1. Active Pharmaceutical Ingredient – Industry snapshot 4.2. Active Pharmaceutical Ingredient Market Dynamics 4.2.1.Drivers and Opportunities 4.2.1.1. Surge in the infectious diseases 4.2.1.2. Growing Importance of Generics -4-
Active Pharmaceutical Ingredient (API) Market Size Worth USD 306.1 billion by 2027
4.2.2.Restraints and Challenges 4.2.2.1. Side effects associated of drugs 4.3. Porter’s Five Forces Analysis 4.3.1.Bargaining Power of Suppliers (Moderate) 4.3.2.Threats of New Entrants: (Low) 4.3.3.Bargaining Power of Buyers (Moderate) 4.3.4.Threat of Substitute (Moderate) 4.3.5.Rivalry among existing firms (High) 4.4. PESTLE Analysis 4.5. Active Pharmaceutical Ingredient Market Industry trends 5. Active Pharmaceutical Ingredient Market Assessment by Product Type 5.1. Key Findings 5.2. Introduction 5.2.1.Global Active Pharmaceutical Ingredient Market, By Product Type, 2015 – 2026 (USD Million) 5.3. Monoclonal Antibodies 5.3.1.Global Active Pharmaceutical Ingredient Market, by Monoclonal Antibodies, by Region, 20162027 (USD Million) 5.4. Immunoglobulin 5.4.1.Global Active Pharmaceutical Ingredient Market, by Immunoglobulin, by Region, 2016- 2027 (USD Million) 5.5. Cytokines 5.5.1.Global Active Pharmaceutical Ingredient Market, by Cytokines, by Region, 2016- 2027 (USD Million) 5.6. Insulin 5.6.1.Global Active Pharmaceutical Ingredient Market, by Insulin, by Region, 2016- 2027 (USD Million) 5.7. Peptide Hormones 5.7.1.Global Active Pharmaceutical Ingredient Market, by Peptide Hormones, by Region, 2016- 2027 (USD Million) 5.8. Blood Factors 5.8.1.Global Active Pharmaceutical Ingredient Market, by Blood Factors, by Region, 2016- 2027 (USD Million) 5.9. Peptide Antibiotics 5.9.1.Global Active Pharmaceutical Ingredient Market, by Peptide Antibiotics, by Region, 2016- 2027 (USD Million) 5.10. Vaccines 5.10.1. Global Active Pharmaceutical Ingredient Market, by Vaccines, by Region, 2016- 2027 (USD Million) 5.11. Small Molecule Antibiotics 5.11.1. Global Active Pharmaceutical Ingredient Market, by Small Molecule Antibiotics, by Region, 2016- 2027 (USD Million) 5.12. Highly Potent Active Pharmaceutical Ingredient (HPAPI) 5.12.1. Global Active Pharmaceutical Ingredient Market, by Highly Potent Active Pharmaceutical Ingredient (HPAPI), by Region, 2016- 2027 (USD Million) 5.13. Others 5.13.1. Global Active Pharmaceutical Ingredient Market, by Others, by Region, 2016- 2027 (USD Million) 6. Global Active Pharmaceutical Ingredient Market, by Form 6.1. Key Findings 6.2. Introduction 6.2.1.Global Active Pharmaceutical Ingredient Market, By Form, 2015 – 2026 (USD Million) -5-
Active Pharmaceutical Ingredient (API) Market Size Worth USD 306.1 billion by 2027
6.3. Aqueous 6.3.1.Global Active Pharmaceutical Ingredient Market, by Aqueous, By Region, 2016- 2027 (USD Million) 6.4. Non-Aqueous Liquid 6.4.1.Global Active Pharmaceutical Ingredient Market, by Non-Aqueous Liquid, by Region, 20162027 (USD Million) 6.5. Dry Powder 6.5.1.Global Active Pharmaceutical Ingredient Market, by Dry Powder, by Region, 2016- 2027 (USD Million) 7. Global Active Pharmaceutical Ingredient Market, by Manufacturer 7.1. Key Findings 7.2. Introduction 7.2.1.Global Active Pharmaceutical Ingredient Market, By Manufacturer, 2015 – 2026 (USD Million) 7.3. Captive 7.3.1.Global Active Pharmaceutical Ingredient Market, by Captive, By Region, 2016- 2027 (USD Million) 7.4. Merchant 7.4.1.Global Active Pharmaceutical Ingredient Market, by Merchant, by Region, 2016- 2027 (USD Million) 8. Active Pharmaceutical Ingredient Market Assessment by Application 8.1. Key Findings 8.2. Introduction 8.2.1.Global Active Pharmaceutical Ingredient Market, By Application, 2015 – 2026 (USD Million) 8.3. Cardiology 8.3.1.Global Active Pharmaceutical Ingredient Market, by Cardiology, by Region, 2016- 2027 (USD Million) 8.4. Oncology 8.4.1.Global Active Pharmaceutical Ingredient Market, by Oncology, by Region, 2016- 2027 (USD Million) 8.5. CNS & Neurology 8.5.1.Global Active Pharmaceutical Ingredient Market, by CNS & Neurology, by Region, 2016- 2027 (USD Million) 8.6. Orthopedic 8.6.1.Global Active Pharmaceutical Ingredient Market, by Orthopedic, by Region, 2016- 2027 (USD Million) 8.7. Endocrinology 8.7.1.Global Active Pharmaceutical Ingredient Market, by Endocrinology, by Region, 2016- 2027 (USD Million) 8.8. Pulmonology 8.8.1.Global Active Pharmaceutical Ingredient Market, by Pulmonology, by Region, 2016- 2027 (USD Million) 8.9. Gastroenterology 8.9.1.Global Active Pharmaceutical Ingredient Market, by Gastroenterology, by Region, 2016- 2027 (USD Million) 8.10. Nephrology 8.10.1. Global Active Pharmaceutical Ingredient Market, by Nephrology, by Region, 2016- 2027 (USD Million) 8.11. Ophthalmology 8.11.1. Global Active Pharmaceutical Ingredient Market, by Ophthalmology, by Region, 2016- 2027 (USD Million) 8.12. Others -6-
Active Pharmaceutical Ingredient (API) Market Size Worth USD 306.1 billion by 2027
8.12.1. Global Active Pharmaceutical Ingredient Market, by Other Applications, by Region, 20162027 (USD Million) 9. Active Pharmaceutical Ingredient Market Assessment by Geography 9.1. Key findings 9.2. Introduction 9.2.1.Active Pharmaceutical Ingredient Market Assessment, By Geography, 2016- 2027 (USD Million) 9.3. Active Pharmaceutical Ingredient Market – North America 9.3.1.North America: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) 9.3.2.North America: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million) 9.3.3.North America: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million) 9.3.4.North America: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) 9.3.5.Active Pharmaceutical Ingredient Market – U.S. 9.3.5.1. U.S.: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) 9.3.5.2. U.S.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million) 9.3.5.3. U.S.: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) 9.3.5.4. U.S.: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) 9.3.6.Active Pharmaceutical Ingredient Market – Canada 9.3.6.1. Canada: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) 9.3.6.2. Canada.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million) 9.3.6.3. Canada: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) 9.3.6.4. Canada: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) 9.4. Active Pharmaceutical Ingredient Market – Europe 9.4.1.Europe: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) 9.4.2.Europe.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million) 9.4.3.Europe: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) 9.4.4.Europe: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) 9.4.5.Active Pharmaceutical Ingredient Market – UK 9.4.5.1. UK: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) 9.4.5.2. UK.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million) 9.4.5.3. UK: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) 9.4.5.4. UK: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) 9.4.6.Active Pharmaceutical Ingredient Market – France 9.4.6.1. France: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) 9.4.6.2. France.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million) 9.4.6.3. France: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) -7-
Active Pharmaceutical Ingredient (API) Market Size Worth USD 306.1 billion by 2027
9.4.6.4. France: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) 9.4.7.Active Pharmaceutical Ingredient Market – Germany 9.4.7.1. Germany: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) 9.4.7.2. Germany.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million) 9.4.7.3. Germany: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) 9.4.7.4. Germany: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) 9.4.8.Active Pharmaceutical Ingredient Market – Italy 9.4.8.1. Italy: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) 9.4.8.2. Italy.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million) 9.4.8.3. Italy: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) 9.4.8.4. Italy: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) 9.4.9.Active Pharmaceutical Ingredient Market – Spain 9.4.9.1. Spain: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) 9.4.9.2. Spain.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million) 9.4.9.3. Spain: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) 9.4.9.4. Spain: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) 9.4.10. Active Pharmaceutical Ingredient Market – Netherlands 9.4.10.1. Netherlands: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) 9.4.10.2. Netherlands.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million) 9.4.10.3. Netherlands: Active Pharmaceutical Ingredient Market, By Manufacturer, 20162027 (USD Million) 9.4.10.4. Netherlands: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) 9.4.11. Active Pharmaceutical Ingredient Market – Austria 9.4.11.1. Austria: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) 9.4.11.2. Austria.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million) 9.4.11.3. Austria: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) 9.4.11.4. Austria: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) 9.5. Active Pharmaceutical Ingredient Market – Asia-Pacific 9.5.1.Asia Pacific: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) 9.5.2.Asia Pacific.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million) 9.5.3.Asia-pacific: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) -8-
Active Pharmaceutical Ingredient (API) Market Size Worth USD 306.1 billion by 2027
9.5.4.Asia-pacific: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) 9.5.5.Active Pharmaceutical Ingredient Market – China 9.5.5.1. China: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) 9.5.5.2. China.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million) 9.5.5.3. China: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) 9.5.5.4. China: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) 9.5.6.Active Pharmaceutical Ingredient Market – India 9.5.6.1. India: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) 9.5.6.2. India.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million) 9.5.6.3. India: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) 9.5.6.4. India: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) 9.5.7.Active Pharmaceutical Ingredient Market – Malaysia 9.5.7.1. Malaysia: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) 9.5.7.2. Malaysia.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million) 9.5.7.3. Malaysia: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) 9.5.7.4. Malaysia: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) 9.5.8.Active Pharmaceutical Ingredient Market – Japan 9.5.8.1. Japan: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) 9.5.8.2. Japan.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million) 9.5.8.3. Japan: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) 9.5.8.4. Japan: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) 9.5.9.Active Pharmaceutical Ingredient Market – Indonesia 9.5.9.1. Indonesia: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) 9.5.9.2. Indonesia.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million) 9.5.9.3. Indonesia: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) 9.5.9.4. Indonesia: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) 9.5.10. Active Pharmaceutical Ingredient Market – South Korea 9.5.10.1. South Korea: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) 9.5.10.2. South Korea.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million) 9.5.10.3. South Korea: Active Pharmaceutical Ingredient Market, By Manufacturer, 20162027 (USD Million)
-9-
Active Pharmaceutical Ingredient (API) Market Size Worth USD 306.1 billion by 2027
9.5.10.4. South Korea: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) 9.6. Active Pharmaceutical Ingredient Market – Middle East & Africa 9.6.1.Middle East & Africa: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) 9.6.2.Middle East & Africa.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million) 9.6.3.Middle East & Africa: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) 9.6.4.Middle East & Africa: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) 9.6.5.Active Pharmaceutical Ingredient Market – Saudi Arabia 9.6.5.1. Saudi Arabia: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) 9.6.5.2. Saudi Arabia.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million) 9.6.5.3. Saudi Arabia: Active Pharmaceutical Ingredient Market, By Manufacturer, 20162027 (USD Million) 9.6.5.4. Saudi Arabia: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) 9.6.6.Active Pharmaceutical Ingredient Market – UAE 9.6.6.1. UAE: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) 9.6.6.2. UAE.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million) 9.6.6.3. UAE: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) 9.6.6.4. UAE: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) 9.6.7.Active Pharmaceutical Ingredient Market – Israel 9.6.7.1. Israel: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) 9.6.7.2. Israel.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million) 9.6.7.3. Israel: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) 9.6.7.4. Israel: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) 9.6.8.Active Pharmaceutical Ingredient Market – South Africa 9.6.8.1. South Africa: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) 9.6.8.2. South Africa.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million) 9.6.8.3. South Africa: Active Pharmaceutical Ingredient Market, By Manufacturer, 20162027 (USD Million) 9.6.8.4. South Africa: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) 9.7. Active Pharmaceutical Ingredient Market – Latin America 9.7.1.Latin America: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) 9.7.2.Latin America.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million) 9.7.3.Latin America: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) - 10 -
Active Pharmaceutical Ingredient (API) Market Size Worth USD 306.1 billion by 2027
9.7.4.Latin America: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) 9.7.5.Active Pharmaceutical Ingredient Market – Mexico 9.7.5.1. Mexico: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) 9.7.5.2. Mexico.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million) 9.7.5.3. Mexico: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) 9.7.5.4. Mexico: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) 9.7.6.Active Pharmaceutical Ingredient Market – Brazil 9.7.6.1. Brazil: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) 9.7.6.2. Brazil.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million) 9.7.6.3. Brazil: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) 9.7.6.4. Brazil: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) 9.7.7.Active Pharmaceutical Ingredient Market – Argentina 9.7.7.1. Argentina: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) 9.7.7.2. Argentina.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million) 9.7.7.3. Argentina: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) 9.7.7.4. Argentina: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) 10. Competitive Landscape 10.1. Expansion and Acquisition Analysis 10.1.1. Expansion & Acquisition 10.2. Partnerships/Collaborations/Agreements/Exhibitions 11. Company Profiles 11.1. AbbVie Inc. 11.1.1. Company Overview 11.1.2. Financial Performance 11.1.3. Product Benchmarking 11.1.4. Recent Development 11.2. Albemarle Corporation 11.2.1. Company Overview 11.2.2. Financial Performance 11.2.3. Product Benchmarking 11.2.4. Recent Development 11.3. AstraZeneca 11.3.1. Company Overview 11.3.2. Financial Performance 11.3.3. Product Benchmarking 11.3.4. Recent Development 11.4. Aurobindo Pharma 11.4.1. Company Overview 11.4.2. Financial Performance - 11 -
Active Pharmaceutical Ingredient (API) Market Size Worth USD 306.1 billion by 2027
11.4.3. Product Benchmarking 11.4.4. Recent Development 11.5. Boehringer Ingelheim 11.5.1. Company Overview 11.5.2. Financial Performance 11.5.3. Product Benchmarking 11.5.4. Recent Development 11.6. Bristol-Myers Squibb 11.6.1. Company Overview 11.6.2. Financial Performance 11.6.3. Product Benchmarking 11.6.4. Recent Development 11.7. Cipla Inc. 11.7.1. Company Overview 11.7.2. Financial Performance 11.7.3. Product Benchmarking 11.7.4. Recent Development 11.8. Dr. Reddy's Laboratories Ltd. 11.8.1. Company Overview 11.8.2. Financial Performance 11.8.3. Product Benchmarking 11.8.4. Recent Development 11.9. ELI Lilly and Company 11.9.1. Company Overview 11.9.2. Financial Performance 11.9.3. Product Benchmarking 11.9.4. Recent Development 11.10. F. Hoffmann-La Roche AG 11.10.1. Company Overview 11.10.2. Financial Performance 11.10.3. Product Benchmarking 11.10.4. Recent Development 11.11. GlaxoSmithKline PLC 11.11.1. Company Overview 11.11.2. Financial Performance 11.11.3. Product Benchmarking 11.11.4. Recent Development 11.12. Lonza Group 11.12.1. Company Overview 11.12.2. Financial Performance 11.12.3. Product Benchmarking 11.12.4. Recent Development 11.13. Merck & Co., Inc. 11.13.1. Company Overview 11.13.2. Financial Performance 11.13.3. Product Benchmarking 11.13.4. Recent Development 11.14. Mylan N.V. 11.14.1. Company Overview 11.14.2. Financial Performance 11.14.3. Product Benchmarking - 12 -
Active Pharmaceutical Ingredient (API) Market Size Worth USD 306.1 billion by 2027
11.14.4. Recent Development 11.15. Novartis AG 11.15.1. Company Overview 11.15.2. Financial Performance 11.15.3. Product Benchmarking 11.15.4. Recent Development 11.16. Pfizer, Inc. 11.16.1. Company Overview 11.16.2. Financial Performance 11.16.3. Product Benchmarking 11.16.4. Recent Development 11.17. Sanofi 11.17.1. Company Overview 11.17.2. Financial Performance 11.17.3. Product Benchmarking 11.17.4. Recent Development 11.18. Sun Pharmaceutical Industries Ltd 11.18.1. Company Overview 11.18.2. Financial Performance 11.18.3. Product Benchmarking 11.18.4. Recent Development 11.19. Teva Pharmaceutical Industries Ltd. 11.19.1. Company Overview 11.19.2. Financial Performance 11.19.3. Product Benchmarking 11.19.4. Recent Development Access Press Release on Active Pharmaceutical Ingredient (API) Market: https://www.polarismarketresearch.com/press-releases/active-pharmaceutical-ingredient-market About Polaris Market Research Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors, and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. E mail Id: sales@polarismarketresearch.com Web: www.polarismarketresearch.com Official Blog: http://polarismarketresearch.blogspot.com - 13 -